Recent studies have demonstrated that low KLF17 is involved in transforming growth factor β (TGF-β) pathway and p53 pathway in human cancer and regulates epithelial-mesenchymal transition (EMT) and participates in metastases. The gene discussed is TP53; the disease is cancer.